X0708 D LIVE 0000894158 Theriva Biologics, Inc. 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD MARYLAND 20850 301-417-4364 NEVADA SYNTHETIC BIOLOGICS, INC. Synthetic Biologics, Inc. ADEONA PHARMACEUTICALS, INC. PIPEX PHARMACEUTICALS, INC. Corporation true Steven A. Shallcross 9605 Medical Center Drive Suite 270 Rockville MD MARYLAND 20850 Executive Officer Director Jeffrey J. Kraws 9605 Medical Center Drive Suite 270 Rockville MD MARYLAND 20850 Director John Monahan 9605 Medical Center Drive Suite 270 Rockville MD MARYLAND 20850 Director Jeffrey A. Wolf 9605 Medical Center Drive Suite 270 Rockville MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b false 2025-10-17 false true true false 0 A.G.P./Alliance Global Partners 000008361 None None 590 MADISON AVENUE 36th Floor New York NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NY NEW YORK true 13109494 13109494 0 Includes $4,369,831.20 in proceeds from exercise of existing registered warrants pursuant to Warrant Inducement Letter Agreement and $8,739,663 in total gross proceeds to be received from cash exercise of all new warrants issued in private placement. false 10 308000 true 0 A.G.P/Alliance Global Partners LP was paid by the Issuer a cash fee equal to 7.0% of the aggregate gross proceeds received upon exercise of the existing registered warrants and reimbursement of certain expenses. 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers false Theriva Biologics, Inc. /s/ Steven A. Shallcross Steven A. Shallcross Chief Executive Officer and Chief Financial Officer 2025-10-23